Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Medical Facilities ( (TSE:DR) ) has shared an announcement.
Medical Facilities Corporation reported a 7.5% increase in facility service revenue for Q3 2025, driven by higher surgical case volumes and favorable payor mix. The company’s income from operations rose by 17.1%, and EBITDA increased by 10.2%, reflecting operational strength. Additionally, MFC returned $5.6 million to shareholders through share buybacks, highlighting its commitment to shareholder value. Despite fluctuations in net income due to non-cash finance costs and income taxes, the company maintains a strong balance sheet with significant cash reserves, indicating a positive outlook for stakeholders.
The most recent analyst rating on (TSE:DR) stock is a Hold with a C$15.50 price target. To see the full list of analyst forecasts on Medical Facilities stock, see the TSE:DR Stock Forecast page.
Spark’s Take on TSE:DR Stock
According to Spark, TipRanks’ AI Analyst, TSE:DR is a Neutral.
The overall stock score of 63 reflects strong valuation metrics and profitability, offset by challenges in revenue growth and cash flow. Technical indicators are neutral, and the earnings call highlighted both achievements and significant challenges. The stock may be undervalued, but operational issues need addressing to improve future performance.
To see Spark’s full report on TSE:DR stock, click here.
More about Medical Facilities
Medical Facilities Corporation operates in the healthcare industry, primarily focusing on providing high-quality surgical services through its specialty hospitals. The company is known for its stable and robust surgical facilities, catering to a diverse patient base and maintaining a strong market presence.
Average Trading Volume: 27,799
Technical Sentiment Signal: Buy
Current Market Cap: C$259.7M
For an in-depth examination of DR stock, go to TipRanks’ Overview page.